Physician Assistant in Cherokee, OK Accepting Medicare
2 Physician Assistant nurses found. Showing 1 - 2
 Taylor Renea Carson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 405 S Oklahoma Ave, Cherokee, OK 73728 Phone: 580-596-2800 |
Niki S Lewis-wyatt, PAC Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 221 S Grand Ave, Cherokee, OK 73728 Phone: 580-307-6263 Fax: 580-603-8602 |
News Archive
Patients on dialysis may face risk of death from atrial fibrillation: Study
The abnormal heart rhythm, atrial fibrillation, is increasingly common in patients on dialysis and is linked to a sharp rise in death, in an already at-risk population, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
LA community clinics facing budget squeeze; Milwaukee may target benefits of public employees; Seattle Times documents 236 deaths in adult homes
Los Angeles Times: "Stung by a budget stalemate that is costing Los Angeles County community clinics more than $330,000 a day in reimbursements, many clinic managers have been forced to take out loans and contemplate cuts to staff and services. Without the funds from Medi-Cal, the state insurance program for low-income patients, 41 clinics statewide have applied for loans from a fund created in response to the budget impasse.
Scientists discover potential trigger for MDS in children with rare genetic disorder
Myelodysplastic syndrome is an umbrella term used to describe disorders characterized by the bone marrow's inability to produce normal blood cells.
Stories can play a role in shifting the importance of moral values in young audiences
An important lesson in the moral education of children could be as close as the book in their hands. Stories matter. And they can play a role in shifting the importance of particular moral values in young audiences, according to the results of a new study.
Dapagliflozin as monotherapy demonstrates potential for type 2 diabetes treatment
Findings from a 24-week Phase 3 clinical study published online in the latest issue of Diabetes Care demonstrated that the investigational drug dapagliflozin, administered as a monotherapy, achieved statistically significant mean reductions at 5 mg and 10 mg doses once daily in the primary endpoint of glycosylated hemoglobin levels (HbA1c) in treatment-naïve adult patients with newly diagnosed type 2 diabetes, compared to placebo.
› Verified 4 days ago